M
2.32
-0.05 (-2.11%)
| 前收盘价格 | 2.37 |
| 收盘价格 | 2.28 |
| 成交量 | 58,962 |
| 平均成交量 (3个月) | 356,644 |
| 市值 | 5,861,781 |
| 价格/销量 (P/S) | 5.45 |
| 股市价格/股市净资产 (P/B) | 0.460 |
| 52周波幅 |
| 营业利益率 (TTM) | -1,304.61% |
| 稀释每股收益 (EPS TTM) | -5.70 |
| 季度收入增长率 (YOY) | 15.50% |
| 总债务/股东权益 (D/E MRQ) | 2.06% |
| 流动比率 (MRQ) | 0.380 |
| 营业现金流 (OCF TTM) | -5.98 M |
| 杠杆自由现金流 (LFCF TTM) | -2.16 M |
| 资产报酬率 (ROA TTM) | -57.51% |
| 股东权益报酬率 (ROE TTM) | -108.44% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | Mangoceuticals, Inc. | - | - |
AIStockmoo 评分
1.1
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 1.13 |
|
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men’s wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 内部持股比例 | 37.45% |
| 机构持股比例 | 4.69% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ackerman Capital Advisors, Llc | 30 Sep 2024 | 58,227 |
| Desjardins Global Asset Management Inc. | 31 Dec 2023 | 0 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合